Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36


A National Survey of Profiles of Clerkship Directors in Obstetrics and Gynecology.

Morgan HK, Graziano SC, Craig LB, Everett EN, Forstein DA, Hampton BS, Hopkins L, McKenzie ML, Pradhan A, Royce C, Madani-Sims S, Morosky CM; Undergraduate Medical Education Committee, Association of Professors of Gynecology and Obstetrics.

Obstet Gynecol. 2019 Oct;134(4):869-873. doi: 10.1097/AOG.0000000000003471.


Teaching Critical Thinking: A Case for Instruction in Cognitive Biases to Reduce Diagnostic Errors and Improve Patient Safety.

Royce CS, Hayes MM, Schwartzstein RM.

Acad Med. 2019 Feb;94(2):187-194. doi: 10.1097/ACM.0000000000002518.


Faculty perspectives on the use of standardized versus non-standardized oral examinations to assess medical students.

Johnson N, Khachadoorian-Elia H, Royce C, York-Best C, Atkins K, Chen XP, Pelletier A.

Int J Med Educ. 2018 Sep 29;9:255-261. doi: 10.5116/ijme.5b96.17ca.


In Reply.

Baecher-Lind L, Abbott J, Atkins KM, Royce C, Ricciotti HA, Nijjar JB, Schiff L.

Obstet Gynecol. 2018 Sep;132(3):784. doi: 10.1097/AOG.0000000000002847. No abstract available.


A Call to Action to Address Gender Equity Within Our Specialty: Time's Up on Waiting for Change.

Baecher-Lind L, Abbott J, Atkins KM, Nijjar JB, Royce C, Schiff L, Ricciotti HA.

Obstet Gynecol. 2018 Jun;131(6):961-963. doi: 10.1097/AOG.0000000000002639.


Clinical Trials and the Role of the Oncology Clinical Trials Nurse.

Ness EA, Royce C.

Nurs Clin North Am. 2017 Mar;52(1):133-148. doi: 10.1016/j.cnur.2016.10.005. Review.


Teaching Patient Handoffs to Medical Students in Obstetrics and Gynecology: Simulation Curriculum and Assessment Tool.

Royce CS, Atkins KM, Mendiola M, Ricciotti H.

MedEdPORTAL. 2016 Oct 2;12:10479. doi: 10.15766/mep_2374-8265.10479.


HLA B*5701-positive long-term nonprogressors/elite controllers are not distinguished from progressors by the clonal composition of HIV-specific CD8+ T cells.

Mendoza D, Royce C, Ruff LE, Ambrozak DR, Quigley MF, Dang T, Venturi V, Price DA, Douek DC, Migueles SA, Connors M.

J Virol. 2012 Apr;86(7):4014-8. doi: 10.1128/JVI.06982-11. Epub 2012 Jan 25.


Single-dose liposomal amphotericin B (AmBisome®) for the treatment of visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial.

Edwards T, Omollo R, Khalil EA, Yifru S, Musa B, Musa A, Wasunna M, Smith PG, Royce C, Ellis S, Balasegaram M, Hailu A.

Trials. 2011 Mar 6;12:66. doi: 10.1186/1745-6215-12-66.


Paromomycin for the treatment of visceral leishmaniasis in Sudan: a randomized, open-label, dose-finding study.

Musa AM, Younis B, Fadlalla A, Royce C, Balasegaram M, Wasunna M, Hailu A, Edwards T, Omollo R, Mudawi M, Kokwaro G, El-Hassan A, Khalil E.

PLoS Negl Trop Dis. 2010 Oct 26;4(10):e855. doi: 10.1371/journal.pntd.0000855.


Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial.

Hailu A, Musa A, Wasunna M, Balasegaram M, Yifru S, Mengistu G, Hurissa Z, Hailu W, Weldegebreal T, Tesfaye S, Makonnen E, Khalil E, Ahmed O, Fadlalla A, El-Hassan A, Raheem M, Mueller M, Koummuki Y, Rashid J, Mbui J, Mucee G, Njoroge S, Manduku V, Musibi A, Mutuma G, Kirui F, Lodenyo H, Mutea D, Kirigi G, Edwards T, Smith P, Muthami L, Royce C, Ellis S, Alobo M, Omollo R, Kesusu J, Owiti R, Kinuthia J; Leishmaniasis East Africa Platform (LEAP) group.

PLoS Negl Trop Dis. 2010 Oct 26;4(10):e709. doi: 10.1371/journal.pntd.0000709.


Length of positive surgical margin after radical prostatectomy as a predictor of biochemical recurrence.

Shikanov S, Song J, Royce C, Al-Ahmadie H, Zorn K, Steinberg G, Zagaja G, Shalhav A, Eggener S.

J Urol. 2009 Jul;182(1):139-44. doi: 10.1016/j.juro.2009.02.139. Epub 2009 May 17.


Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsiveness.

Jagannathan P, Osborne CM, Royce C, Manion MM, Tilton JC, Li L, Fischer S, Hallahan CW, Metcalf JA, McLaughlin M, Pipeling M, McDyer JF, Manley TJ, Meier JL, Altman JD, Hertel L, Davey RT Jr, Connors M, Migueles SA.

J Virol. 2009 Mar;83(6):2728-42. doi: 10.1128/JVI.02128-08. Epub 2009 Jan 7.


Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma.

Kreisl TN, Kim L, Moore K, Duic P, Royce C, Stroud I, Garren N, Mackey M, Butman JA, Camphausen K, Park J, Albert PS, Fine HA.

J Clin Oncol. 2009 Feb 10;27(5):740-5. doi: 10.1200/JCO.2008.16.3055. Epub 2008 Dec 29.


Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control.

Migueles SA, Osborne CM, Royce C, Compton AA, Joshi RP, Weeks KA, Rood JE, Berkley AM, Sacha JB, Cogliano-Shutta NA, Lloyd M, Roby G, Kwan R, McLaughlin M, Stallings S, Rehm C, O'Shea MA, Mican J, Packard BZ, Komoriya A, Palmer S, Wiegand AP, Maldarelli F, Coffin JM, Mellors JW, Hallahan CW, Follman DA, Connors M.

Immunity. 2008 Dec 19;29(6):1009-21. doi: 10.1016/j.immuni.2008.10.010. Epub 2008 Dec 8.


A phase I trial of lenalidomide in patients with recurrent primary central nervous system tumors.

Fine HA, Kim L, Albert PS, Duic JP, Ma H, Zhang W, Tohnya T, Figg WD, Royce C.

Clin Cancer Res. 2007 Dec 1;13(23):7101-6.


Liposomal amphotericin B for the treatment of visceral leishmaniasis.

Bern C, Adler-Moore J, Berenguer J, Boelaert M, den Boer M, Davidson RN, Figueras C, Gradoni L, Kafetzis DA, Ritmeijer K, Rosenthal E, Royce C, Russo R, Sundar S, Alvar J.

Clin Infect Dis. 2006 Oct 1;43(7):917-24. Epub 2006 Aug 28.


To fully tackle the gang of four, needs-driven R & D is essential.

Torreele E, Royce C, Don R, Sevcsik AM, Croft S.

PLoS Med. 2006 Jun;3(6):e282; author reply e284. Epub 2006 Jun 27. No abstract available.


Visceral leishmaniasis: new health tools are needed.

Hailu A, Musa AM, Royce C, Wasunna M.

PLoS Med. 2005 Jul;2(7):e211. Epub 2005 Jul 26. Review. No abstract available.


The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences.

Migueles SA, Laborico AC, Imamichi H, Shupert WL, Royce C, McLaughlin M, Ehler L, Metcalf J, Liu S, Hallahan CW, Connors M.

J Virol. 2003 Jun;77(12):6889-98.


Increasing membrane-bound MCSF does not enhance OPGL-driven osteoclastogenesis from marrow cells.

Fan X, Fan D, Gewant H, Royce CL, Nanes MS, Rubin J.

Am J Physiol Endocrinol Metab. 2001 Jan;280(1):E103-11.


Hyperglycemia alone does not inhibit secretin-induced pancreatic bicarbonate secretion.

Simon T, Marcus A, Royce CL, Chao F, Mendez T, Fink AS.

Pancreas. 2000 Apr;20(3):277-81.


A randomized, double-blind, comparative trial of a new oral combination of artemether and benflumetol (CGP 56697) with mefloquine in the treatment of acute Plasmodium falciparum malaria in Thailand.

Looareesuwan S, Wilairatana P, Chokejindachai W, Chalermrut K, Wernsdorfer W, Gemperli B, Gathmann I, Royce C.

Am J Trop Med Hyg. 1999 Feb;60(2):238-43.


Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years.

Hatz C, Abdulla S, Mull R, Schellenberg D, Gathmann I, Kibatala P, Beck HP, Tanner M, Royce C.

Trop Med Int Health. 1998 Jun;3(6):498-504.


A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children.

von Seidlein L, Bojang K, Jones P, Jaffar S, Pinder M, Obaro S, Doherty T, Haywood M, Snounou G, Gemperli B, Gathmann I, Royce C, McAdam K, Greenwood B.

Am J Trop Med Hyg. 1998 May;58(5):638-44.


Phase II trial in China of a new, rapidly-acting and effective oral antimalarial, CGP 56697, for the treatment of Plasmodium falciparum malaria.

Jiao X, Liu GY, Shan CO, Zhao X, Li XW, Gathmann I, Royce C.

Southeast Asian J Trop Med Public Health. 1997 Sep;28(3):476-81.


Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria.

van Vugt M, Brockman A, Gemperli B, Luxemburger C, Gathmann I, Royce C, Slight T, Looareesuwan S, White NJ, Nosten F.

Antimicrob Agents Chemother. 1998 Jan;42(1):135-9.


Treatment of African children with uncomplicated falciparum malaria with a new antimalarial drug, CGP 56697.

von Seidlein L, Jaffar S, Pinder M, Haywood M, Snounou G, Gemperli B, Gathmann I, Royce C, Greenwood B.

J Infect Dis. 1997 Oct;176(4):1113-6.


Clinical use of aromatase inhibitors in the treatment of advanced breast cancer.

Trunet PF, Vreeland F, Royce C, Chaudri HA, Cooper J, Bhatnagar AS.

J Steroid Biochem Mol Biol. 1997 Apr;61(3-6):241-5. Review.


Starvation in hospital. Identifying malnutrition benefits everybody.

Royce C, Taylor M.

BMJ. 1994 May 21;308(6940):1370. No abstract available.


A patient's charter for laboratories.

Bulusu S, Royce CM.

BMJ. 1992 Mar 7;304(6827):642-3. No abstract available.


Postoperative intra-abdominal sepsis.

Royce C, Taylor M, Karran SJ.

Br J Surg. 1988 Apr;75(4):396. No abstract available.


To tunnel or not to tunnel catheters for parenteral nutrition.

Royce C.

Ann R Coll Surg Engl. 1988 Jan;70(1):59-60. No abstract available.


Prevention of infection in high risk biliary operations.

Karran SJ, de la Hunt M, Townend I, Tasker G, Walmsley B, McDonald P, Royce C, Goh H, Dawes R, Smallwood J, et al.

Antibiot Chemother (1971). 1985;33:59-72. Review. No abstract available.


Bilateral carcinoma of the breast.

Bailey MJ, Royce C, Sloane JP, Ford HT, Powles TJ, Gazet JC.

Br J Surg. 1980 Jul;67(7):514-6.


A television scanner for the ultracentrifuge. II. Multiple cell operation.

Rockholt DL, Royce CR, Richards EG.

Biophys Chem. 1976 Jul;5(1-2):55-75.


Supplemental Content

Support Center